In addition to tamoxifen and the three aromatase inhibitors (AIs) anastrozole, letrozole, and exemestane, with fulvestrant, a selective estrogen receptor degrader (SERD), there are several ET options available for aBC patients [5,6,7]. This evidence concerns the gene ESR1 and aneurysmal bone cyst.